Santiago, Chile, and three of P. aeruginosa (49-4583, 49-4596, and 49-4597) recovered from respiratory tract samples between August and September 2002 from the same hospital in Caracas, Venezuela, were obtained as part of the SENTRY Antimicrobial Surveillance Program. According to results of MIC tests performed as described by the National Committee for Clinical Laboratory Standards, the isolates were resistant to all ␤-lactams, aminoglycosides, quinolones, and other antimicrobial agents tested (Table 1) . Only polymyxin B was active against all the isolates. MBL phenotypic tests were positive as judged by the disk approximation method (imipenem, meropenem, ceftazidime, EDTA, and 2-mercaptopropionic acid) and the Etest MBL strips (AB Biodisk, Solna, Sweden) (7). These results were confirmed by spectrophotometric assays measuring imipenem hydrolysis, as previously described (4). Imipenem hydrolysis was inhibited by 88 to 97% for each of the strains by EDTA (20 mM) ( Table 2) .
Amplification with primers for the internal region of bla VIMlike genes and 5Ј conserved sequence and 3Ј conserved sequence from class 1 integron and subsequent sequencing were performed as described earlier (3, 5) . Primers used for amplification and sequencing of the bla VIM gene were VIM-F (5Ј-AAAGTTATGCCGCACTCACC-3Ј) and VIM-R (5Ј-TGCA ACTTCATGTTATGCCG-3Ј).
Sequencing results of the PCR amplicons revealed the presence of the bla VIM-2 gene in the first position of a class 1 integron, which has qacE⌬/su1l downstream of the MBL gene. This integron gene arrangement has been previously reported for a P. aeruginosa isolate from a patient in France in 1996 (3). Other cases have been reported from P. aeruginosa in Greece in 2000 and from Serratia marcescens in Korea in 2002 (6, 8) . Class 1 integrons carrying bla VIM -type genes are now reported to contain genes encoding aminoglycoside-modifying enzymes, and it is uncertain whether the arrangement of the integron without the additional genes is the progenitor.
Despite repeated attempts, plasmid DNA analysis of the isolates did not show any plasmids, and transformation experiments were unsuccessful. Experiments in conjugation between the clinical isolates and Escherichia coli K-12 Rif r did not yield any transconjugants. These data imply that the bla VIM-2 found in these isolates is likely to be chromosomally carried. Auto- mated ribotyping and pulsed-field gel electrophoresis showed that the three isolates from Venezuela are identical, suggesting clonal spread. The strain from Chile was unique and belonged to a different species from those of the other MBL-producing strains. Dissemination of multiresistant bacteria coupled with the plasticity of class 1 integrons suggests that resistance to mainstay anti-Pseudomonas therapies, such as expanded-spectrum cephalosporins and carbapenems, will continue to increase. We urge greater local screening for MBL-producing strains with the disk approximation tests (8; Kurokawa et al., letter) and the Etest MBL strip (7) .
